Benzinga | Oct 21, 2020 04:17PM EDT

Edwards Lifesciences Q3 Adj. EPS $0.51 Beats $0.44 Estimate, Sales $1.14B Beat $1.08B Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.44 by 15.91 percent. This is a 63.83 percent decrease over earnings of $1.41 per share from the same period last year. The company reported quarterly sales of $1.14 billion which beat the analyst consensus estimate of $1.08 billion by 5.56 percent. This is a 4.20 percent increase over sales of $1.09 billion the same period last year.